| Product NDC: | 59762-3718 |
| Proprietary Name: | Triazolam |
| Non Proprietary Name: | triazolam |
| Active Ingredient(s): | .25 mg/1 & nbsp; triazolam |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 59762-3718 |
| Labeler Name: | Greenstone LLC |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA017892 |
| Marketing Category: | NDA AUTHORIZED GENERIC |
| Start Marketing Date: | 19821115 |
| Package NDC: | 59762-3718-4 |
| Package Description: | 10 BOTTLE in 1 PACKAGE (59762-3718-4) > 10 TABLET in 1 BOTTLE |
| NDC Code | 59762-3718-4 |
| Proprietary Name | Triazolam |
| Package Description | 10 BOTTLE in 1 PACKAGE (59762-3718-4) > 10 TABLET in 1 BOTTLE |
| Product NDC | 59762-3718 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | triazolam |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19821115 |
| Marketing Category Name | NDA AUTHORIZED GENERIC |
| Labeler Name | Greenstone LLC |
| Substance Name | TRIAZOLAM |
| Strength Number | .25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Benzodiazepine [EPC],Benzodiazepines [Chemical/Ingredient] |